First Time Loading...

Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262

Watchlist Manager
Jiangsu Nhwa Pharmaceutical Co Ltd Logo
Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
Watchlist
Price: 23.45 CNY -0.38% Market Closed
Updated: Jun 11, 2024

Jiangsu Nhwa Pharmaceutical Co Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiangsu Nhwa Pharmaceutical Co Ltd
Other Operating Expenses Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
Other Operating Expenses
¥49.2m
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Operating Expenses
-¥64.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Operating Expenses
¥24m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Operating Expenses
¥421.5m
CAGR 3-Years
27%
CAGR 5-Years
30%
CAGR 10-Years
115%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Operating Expenses
¥39.7m
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
-22%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Operating Expenses
¥49.1m
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jiangsu Nhwa Pharmaceutical Co Ltd's Other Operating Expenses?
Other Operating Expenses
49.2m CNY

Based on the financial report for Dec 31, 2023, Jiangsu Nhwa Pharmaceutical Co Ltd's Other Operating Expenses amounts to 49.2m CNY.

What is Jiangsu Nhwa Pharmaceutical Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
14%

Over the last year, the Other Operating Expenses growth was 7%. The average annual Other Operating Expenses growth rates for Jiangsu Nhwa Pharmaceutical Co Ltd have been 22% over the past three years , 14% over the past five years .